2026 Global: Chicken Medicine And Vaccines Market -Competitive Review (2032) report
Description
The 2026 Global: Chicken Medicine And Vaccines Market -Competitive Review (2031) report features the global market size and projected growth/decline data for the period 2021 through 2032. The report primarily provides an examination of the business strategies for the ten largest global companies in the market and how their strategies differ.
Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).
The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for chicken medicine and vaccines market by geography and historical trend. The scope of the report extends to sizing of the chicken medicine and vaccines market market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.
The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?
The ten market players in this report and a brief synopsis of their participation in the market are:
Zoetis is a global leader in poultry vaccines and medicines, offering broad-spectrum products such as combined Marek’s disease and infectious bronchitis vaccines and pursuing expanded manufacturing capacity to meet rising demand for poultry immunization. Merck Animal Health (MSD Animal Health) maintains a substantial poultry vaccine portfolio with recombinant and vector vaccines for diseases like Newcastle and avian reovirus, supported by regulatory approvals and strategic acquisitions that broaden its capabilities across species. Boehringer Ingelheim Animal Health delivers integrated vaccine solutions for chickens—including next‑generation single‑dose combinations targeting bursal disease, Newcastle and Marek’s diseases—and collaborates with regional partners to accelerate development and commercialization in high‑growth markets. Elanco provides vaccines as part of a wider poultry health offering, leveraging integrated parasite control, therapeutics and vaccines while pursuing partnerships and targeted initiatives to expand access and application of poultry immunization technologies. Ceva Santé Animale focuses on poultry vector and live attenuated vaccines, with recent launches addressing infectious bronchitis and Newcastle disease and an emphasis on product combinations that reduce handling and improve flock compliance. Phibro Animal Health Corporation specializes in targeted avian vaccines and complementary health products, investing in research for next‑generation vaccine formulations and regional distribution to serve poultry producers confronting endemic viral and bacterial threats. HIPRA concentrates on poultry vaccine innovation—particularly vector and recombinant platforms—positioning itself through specialized product lines and regional expansion to address infectious bronchitis, Marek’s disease and other key avian pathogens. Hester Biosciences and Venkys (Venkateshwara Hatcheries) represent major regional players from India that supply a range of poultry vaccines and biologics tailored for endemic disease profiles, supporting local industry needs through domestic manufacturing and export of vaccines for Newcastle disease, IBD and other common poultry diseases. Biovac and other specialist manufacturers and contract developers contribute niche and localized vaccine production capacity for poultry, enabling supply resilience in markets with specific strain profiles and regulatory requirements while partnering with global firms for technology transfer and scale‑up. Collectively these ten companies shape the chicken medicine and vaccines market by combining broad global portfolios (Zoetis, Merck/MSD, Boehringer, Elanco), specialized vaccine technology and vector platforms (Ceva, HIPRA, Phibro), and regionally dominant manufacturers (Hester, Venkys, Biovac) that address both commercial broiler and layer needs through preventive immunization, combination dosing strategies, and expanding manufacturing footprints to meet growing protein demand and regulatory vaccination programs worldwide.
Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).
The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for chicken medicine and vaccines market by geography and historical trend. The scope of the report extends to sizing of the chicken medicine and vaccines market market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.
The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?
The ten market players in this report and a brief synopsis of their participation in the market are:
Zoetis is a global leader in poultry vaccines and medicines, offering broad-spectrum products such as combined Marek’s disease and infectious bronchitis vaccines and pursuing expanded manufacturing capacity to meet rising demand for poultry immunization. Merck Animal Health (MSD Animal Health) maintains a substantial poultry vaccine portfolio with recombinant and vector vaccines for diseases like Newcastle and avian reovirus, supported by regulatory approvals and strategic acquisitions that broaden its capabilities across species. Boehringer Ingelheim Animal Health delivers integrated vaccine solutions for chickens—including next‑generation single‑dose combinations targeting bursal disease, Newcastle and Marek’s diseases—and collaborates with regional partners to accelerate development and commercialization in high‑growth markets. Elanco provides vaccines as part of a wider poultry health offering, leveraging integrated parasite control, therapeutics and vaccines while pursuing partnerships and targeted initiatives to expand access and application of poultry immunization technologies. Ceva Santé Animale focuses on poultry vector and live attenuated vaccines, with recent launches addressing infectious bronchitis and Newcastle disease and an emphasis on product combinations that reduce handling and improve flock compliance. Phibro Animal Health Corporation specializes in targeted avian vaccines and complementary health products, investing in research for next‑generation vaccine formulations and regional distribution to serve poultry producers confronting endemic viral and bacterial threats. HIPRA concentrates on poultry vaccine innovation—particularly vector and recombinant platforms—positioning itself through specialized product lines and regional expansion to address infectious bronchitis, Marek’s disease and other key avian pathogens. Hester Biosciences and Venkys (Venkateshwara Hatcheries) represent major regional players from India that supply a range of poultry vaccines and biologics tailored for endemic disease profiles, supporting local industry needs through domestic manufacturing and export of vaccines for Newcastle disease, IBD and other common poultry diseases. Biovac and other specialist manufacturers and contract developers contribute niche and localized vaccine production capacity for poultry, enabling supply resilience in markets with specific strain profiles and regulatory requirements while partnering with global firms for technology transfer and scale‑up. Collectively these ten companies shape the chicken medicine and vaccines market by combining broad global portfolios (Zoetis, Merck/MSD, Boehringer, Elanco), specialized vaccine technology and vector platforms (Ceva, HIPRA, Phibro), and regionally dominant manufacturers (Hester, Venkys, Biovac) that address both commercial broiler and layer needs through preventive immunization, combination dosing strategies, and expanding manufacturing footprints to meet growing protein demand and regulatory vaccination programs worldwide.
Table of Contents
32 Pages
- 1.0 Scope of Report and Methodology
- 2.0 Market SWOT Analysis and Players
- 2.1 Market Definition
- 2.2 Market Segments
- 2.3 Market Strengths
- 2.4 Market Weaknesses
- 2.5 Market Threats
- 2.6 Market Opportunities
- 2.7 Major Players
- 3.0 Competitive Analysis
- 3.1 Market Player 1
- 3.2 Market Player 2
- 3.3 Market Player 3
- 3.4 Market Player 4
- 3.5 Market Player 5
- 3.6 Market Player 6
- 3.7 Market Player 7
- 3.8 Market Player 8
- 3.9 Market Player 9
- 3.10 Market Player 10
- 4.0 Comparative Business Strategies
- 4.1 Comparative Business Strategies of Player 1 and 2
- 4.2 Comparative Business Strategies of Player 1 and 3
- 4.3 Comparative Business Strategies of Player 1 and 4
- 4.4 Comparative Business Strategies of Player 2 and 3
- 4.5 Comparative Business Strategies of Player 2 and 4
- 4.6 Comparative Business Strategies of Player 3 and 4
- 5.0 Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.